holy
- Joined
- Nov 5, 2024
- Posts
- 592
- Reputation
- 1,053
[warning: this is a purely hypothetical, speculative guide based on genetic, molecular, and developmental biology principles. i am not a licensed clinician, molecular biologist, or bioengineer in your jurisdiction, nor do i condone or recommend the use of unregulated biomedical technologies on yourself or others. genetic modification in humans, especially with the goal of increasing stature postnatally, carries high risk of oncogenesis, systemic dysfunction, and irreversible tissue damage. this text is not medical advice, and it is not ethically or legally sanctioned. if you try to implement anything you read here, you are not just playing god, you’re playing god while drunk, blindfolded, and driving at 160 km/h on ice. do not attempt. do not source DIY CRISPR kits from forums. do not treat your endocrine axis like a videogame. this is educational fiction designed for theoretical analysis, not implementation. now read if you're ready to step into the deep end of posthuman developmental hacking.]
human height is a polygenic quantitative trait, influenced by over 700 gene loci identified in GWAS studies, with most contributing marginal effects, usually fractions of centimeters. some genes, however, have large-effect mutations, mostly found in people with gigantism or short stature syndromes. modifying these would be your entry point.
to attempt height increase through genetic modification, you must divide your strategy into developmental window manipulation and anabolic pathway enhancement.
first, if you're post-pubertal, your epiphyseal growth plates are fused. this means the classic longitudinal bone growth mechanism (chondrocyte proliferation in the growth plate cartilage leading to endochondral ossification) is done. adult humans don’t grow taller because their growth plates are ossified and dead. to reverse this, you’d need to de-differentiate fused bone epiphyses or re-induce a pseudo-growth plate. this would require reactivation of developmental pathways like Ihh/PTHrP signaling, local expression of Sox9, Runx2, and BMP2, and inhibition of ossification via Noggin or Gremlin. you'd essentially attempt to trick your body into thinking the bone is in an adolescent growth stage.
but reactivating growth zones without a full body reset is like trying to regrow your umbilical cord. realistically, the safer, cleaner path is to induce intramembranous ossification in existing bone shafts, meaning you increase height by enhancing periosteal or appositional bone growth, or stimulating limb segment elongation through MSC-mediated osteogenesis, not by trying to recreate natural endochondral growth plates.
gene targets:
1. ACAN (Aggrecan). this proteoglycan is critical for cartilage structure in the growth plate. gain-of-function variants increase height significantly. you’d need to deliver this via AAV to growth-relevant regions (e.g., femur, tibia periosteum).
2. NPR2 (Natriuretic Peptide Receptor B). controls cGMP production and promotes chondrocyte hypertrophy. overexpression leads to taller stature in both humans and animal models. transgenic mice with elevated NPR2 expression show significant overgrowth. you'd use a CRISPRa system targeting this locus, delivered with high specificity to bone-forming regions.
3. IGF1 (Insulin-like Growth Factor 1). key mediator of growth hormone. systemic overexpression leads to both muscle and bone growth, but high circulating IGF1 is strongly associated with cancer risk, especially in colon, prostate, and breast tissues. local overexpression near long bones could work but would need insulated control systems to prevent tumorigenesis.
4. GDF5 (Growth Differentiation Factor 5). promotes cartilage and joint formation. a gain-of-function polymorphism in GDF5 is associated with longer limbs. targeted editing to simulate this SNP (rs143383) could result in limb elongation over time, especially when combined with growth stimulants.
5. SHOX (Short Stature Homeobox). located in pseudoautosomal regions of the X and Y chromosomes. mutations here cause short stature syndromes. enhancing SHOX expression could theoretically reverse or mitigate postnatal growth limitations, though timing is key. post-fusion reactivation would be largely ineffective unless paired with chondrocyte lineage reprogramming.
delivery method:
you'd need a composite delivery system.
AAV vectors (specifically AAV9 or AAVrh10 for skeletal muscle and bone tropism) would be used for gene delivery. CRISPR-Cas9 or CRISPRa constructs would be encapsulated with tissue-specific promoters (e.g., osteocalcin promoter, collagen II promoter, or SOX9 response elements) to target osteoblasts or chondrocyte progenitors. dual AAV systems might be needed if the payload exceeds capsid capacity.
a more exotic but promising method involves exosome-mediated delivery of mRNA or miRNA modulators. bone marrow MSCs can be engineered to produce exosomes carrying synthetic mRNA for IGF1, NPR2, or GDF5, then reintroduced into the body to home toward skeletal tissue. this avoids immune detection and doesn’t trigger long-term Cas protein presence, but delivery efficiency is low and needs constant repetition.
co-factors and hormonal environment:
you cannot just throw genes into a hostile metabolic environment and expect them to flourish. you'd need to:
1. maintain high circulating GH (growth hormone), either endogenously via GHRH agonists or exogenously via rhGH.
2. prevent premature ossification by modulating estrogen pathways, particularly through selective estrogen receptor modulators (SERMs) that reduce estrogenic activity in bone without tanking your hormonal profile systemically.
3. enhance mineral availability: calcium, phosphorus, vitamin D3, K2, magnesium. your bones need raw material.
4. maintain high mTORC1 activity in skeletal tissues while avoiding systemic overload. this ensures protein synthesis and anabolic drive is targeted, not wasted.
timing:
best results would come during late puberty or just before full epiphyseal fusion. post-fusion, expect only partial gains unless you literally induce de novo growth plates, which is an oncogenic nightmare waiting to happen. if you’re fully matured, expect millimeter-per-year growth via periosteal thickening, tibial or femoral stretching, or vertebral disc expansion, not dramatic 10cm jumps (you'd be surprised about the amount of people with this expectation)
off-target risks:
- cancer, especially osteosarcoma from uncontrolled osteoblast proliferation
- vascular overgrowth or ossification of soft tissue
- hormonal collapse from feedback dysregulation
- skeletal deformity due to asymmetric growth stimulation
- pain and nerve compression from altered biomechanics
- immunogenicity from persistent Cas or foreign protein expression
- systemic autoimmune responses from misdirected expression
you'd need to actively monitor with:
1. periodic DEXA scans for bone density and growth mapping
2. full blood panels every 2–4 weeks, including IGF1, GH, estrogen/testosterone, inflammatory markers
3. MRI for vascular and structural assessment
4. gene expression assays via biopsy or blood cfDNA (cell-free DNA) if possible
gene-editing for height isn't clean, it isn’t simple, and the current tech isn't fine-tuned enough for safe self-application. limb lengthening surgery, barbaric as it is, works because it uses your body's natural healing process. gene therapy would be trying to rewrite the instruction manual mid-print. if anything fails or goes uneven, you don’t just stay short, you stay short and broken lmfao
but yeah, theoretically, with full control over targeted AAV delivery, localized CRISPRa/CRISPRi modulation, controlled hormonal stimulation, skeletal tissue-specific expression, and tightly regulated post-transcriptional switches, you could make an adult body grow taller. slow, dirty, but possible.
just not something you should ever try unless you’re ready to roll dice with cancer, bone deformity, chronic pain, and bioethical exile lol
